Group 1 - The company held its shareholder meeting on September 8, 2025, at its conference room located at 788 Torch Avenue, High-tech Development Zone, Nanchang, Jiangxi Province [1] - The meeting was presided over by Chairman Liu Weiquan and utilized a combination of on-site and online voting methods, which complied with the Company Law and the Articles of Association [1] - All 9 current directors and 3 current supervisors attended the meeting, along with the board secretary and other senior executives [1] Group 2 - The first resolution regarding the 2025 semi-annual profit distribution plan was approved [2] - The second resolution concerning the reappointment of the auditing firm for 2025 was also approved [2] - Both resolutions required separate voting for minority investors [2] Group 3 - The legal firm Guohao Law Firm (Shanghai) provided witness services for the meeting, with lawyers Zhang Letian and Wu Haonan present [3] - The legal opinion confirmed that the meeting's convening and procedures complied with legal regulations and the Articles of Association, and that the qualifications of the conveners and attendees were valid [3]
江中药业股份有限公司 2025年第一次临时股东大会决议公告